{"entity":{"id":"nct07222969","kind":"trial","name":"A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors","aka":[],"tldr":"A phase 1/2 trial of VIB305 for Injection in advanced solid tumours, run by Vibrant Sciences Limited, now recruiting.","summary":"A Clinical Study to Evaluate the Safety of VIB305 in Patients With Advanced Solid Tumors is a phase 1/2 interventional study registered as NCT07222969 by Vibrant Sciences Limited, with 146 participants planned, started 2026-01-12 and due to reach its primary completion in 2027-04-30. Interventions recorded: VIB305 for Injection.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07222969","url":"https://clinicaltrials.gov/study/NCT07222969"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["metastatic-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07222969","phase":"1/2","setting":"An Open-label, Dose-escalation and Dose-expansion Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic (PK) Characteristics, and Preliminary Efficacy of VIB305 in Patients With Advanced Solid Tumors","sponsor":"Vibrant Sciences Limited","enrolled":146,"outcomes":[]},"route":"/trials/nct07222969/","neighbours":{"cancer":[{"id":"metastatic-cancer","kind":"cancer","name":"Metastatic cancer (cancer that has spread)","route":"/cancers/metastatic-cancer/"}]}}